Under the proposed changes, there would be an overall negative reimbursement for the category of items, services and procedures under the Medicare Inpatient Prospective Payment System.
Citing an “overly stringent criteria for new-technology add-on payments,” MDMA said some devices might not meet the cost threshold under the proposal.
Read the MDMA release on medical device payments.
Read the full MDMA comments to CMS (pdf).
Related Articles on the Medical Device Manufacturers Association:
MDMA: GPOs Should Be Included in “Sunshine” Provisions
MDMA Announces Support of Legislation to Strengthen the Research & Development Tax Credit
MDMA Applauds Bills to Repeal Medical Device Tax
